Morphine Dosage in Mild Renal Impairment
Introduction to Morphine Use in Renal Impairment
- The European Society for Medical Oncology (ESMO) guidelines recommend using morphine with caution and at reduced doses and frequency in the presence of renal impairment, and suggest considering fentanyl and buprenorphine as safer alternatives 1, 2, 3
Dosing Considerations
- Reduce the starting dose of morphine by 25-50% in patients with mild renal impairment, and extend the dosing interval from every 4 hours to every 6-8 hours for immediate-release formulations 1, 2, 3
- The American College of Physicians and other guideline societies implicitly support the use of fentanyl and buprenorphine as safer choices in renal impairment, due to their minimal renal clearance and lack of active metabolites 4
Opioid Selection and Monitoring
- Assess renal function before initiating opioid therapy, and consider alternative opioids such as fentanyl or buprenorphine in patients with moderate to severe renal impairment 1, 2, 4
- Monitor patients for signs of opioid toxicity, including myoclonus, excessive sedation, confusion, and respiratory depression, and switch to a safer opioid if toxicity occurs 4
Transitioning to Safer Opioids
- When transitioning a patient from morphine to fentanyl or buprenorphine, calculate the total 24-hour morphine equivalent daily dose (MEDD) and convert to the new opioid using a standard conversion ratio, reducing the dose by 25-50% to account for incomplete cross-tolerance 4, 5, 6